Emergent BioSolutions (EBS) is up 9.7%, or 54c to $6.03.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent Biosolutions: Strong Operational Efficiency and Strategic Advancements Justify Buy Rating
- Emergent BioSolutions: Strong Q1 Performance and Strategic Growth Drive Buy Rating
- Emergent BioSolutions’ Earnings Call: A Balanced Outlook
- Emergent BioSolutions rises 29.3%
- Emergent BioSolutions rises 22.4%